+ 12,3 % bei Geron (902213) Was ist los? o. T.

orderbuch:gern bitte eingeben
http://www.level2stockquotes.com/level-ii-quotes.html

vor & nachbörsliche kurse
http://data.cnbc.com/quotes/gern

http://www.mffais.com/gern.html  

 

 

 

von 81 % aber heute von 970 T % hier kann nur ein riesiger Fehler sein. ( NAsdaq)  

 

BioTime makes offer for Geron stem cell assets

NEW YORK — Biotechnology company BioTime Inc. on Thursday proposed two transactions that would combine its stem cell therapy assets with those of Geron Corp.

In a letter to Geron shareholders, BioTime suggests two deals that would form a new publicly traded company owning Geron's stem cell assets with some of BioTime's. It said Geron could have a stake of up to 45 percent in the company, which would also hold $40 million in BioTime stock along with shares of some BioTime stem cell subsidiaries. Geron shareholders would also receive BioTime stock-purchase warrants now valued at about $13 million.

Geron, of Menlo Park, Calif., was a pioneering developer of stem cell therapies. But in November 2011 it said it would exit that business and focus on development of other products, including its experimental cancer drug imetelstat.

"Nearly a year has now passed, and Geron has not announced any transaction that would provide value to either Geron or its shareholders from those stem cell assets," BioTime said in a press release. The Alameda, Calif., company said Geron shareholders should contact the board of directors and urge the company to have discussions with BioTime.

Geron did not immediately respond to a request for comment.

BioTime was founded by former Geron scientists, and when Geron said it was ending its stem cell business, analysts said BioTime was one of the companies that might be interested in buying its treatments.

Geron shares rose 12 cents, or 8.5 percent, to $1.54 in afternoon trading. Shares of BioTime lost 4 cents to $3.95.

http://www.cbsnews.com/8301-505245_162-57535208/...-stem-cell-assets/

 

kommt sie noch was höher?  

M.Erachtens hat die Aktie den Ausbruch geschafft, die 200TL ist überwunden, es dürfte
aufwärts gehen. Habe die Aktie bei 1,058 € am 27.6.13 gekauft und hoffe auf 100%.
Falls es mehr sein sollte, prima.  

Heute hat die Aktie 9,7% gemacht, sie stieg auf 1,27 €, welche Stärke.  

http://www.godmode-trader.de/nachricht/...ehnte-2-welle,a3213686.html  

100 %. Ich bin direkt stolz, das ich gute Nerven hatte und nicht früher verkauft habe.
Für 1,058 gekauft und für 2,25 verkauft.  

http://www.thestreet.com/story/12099582/1/...fibrosis-4-crs-1-pr.html  

 

wo nix geschrieben wird bekomme ich die beste performance  

 

 

 

 

informieren. Hab den Verlauf völlig verpennt. Danke  

 

 

 

dann steht sie wieder auf dem Ausgangspunkt..  

und deutlich über Pari - ich denke da kommt heute was :-)

NmM